Biogen

Biogen is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases to patients worldwide.

History

Biogen was founded in 1978 by several prominent biologists, including Nobel Prize winners Walter Gilbert and Phillip Sharp. The company's name is a portmanteau of "biological" and "genetic".

Products and Services

Biogen's products are focused on treating diseases in the areas of neurology, immunology, and hematology. Some of their most well-known products include Tecfidera, Avonex, and Tysabri, which are used to treat multiple sclerosis, and Spinraza, which is used to treat spinal muscular atrophy.

Research and Development

Biogen has a robust research and development program, with a focus on neurology and neurodegenerative diseases. The company is also involved in the research and development of therapies for autoimmune diseases and hematology.

Controversies

Biogen has faced several controversies over the years, including lawsuits related to patent infringement and pricing of their products.

See Also

• Biotechnology
• Neurodegenerative diseases
• Autoimmune diseases
• Hematology

External Links

• Official website

Biogen Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski